{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:59Z","timestamp":1792783079509,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union within the VITAL Horizon Europe project","award":["101136728"],"award-info":[{"award-number":["101136728"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union within the VITAL Horizon Europe project","award":["101136728"],"award-info":[{"award-number":["101136728"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union within the VITAL Horizon Europe project","award":["101136728"],"award-info":[{"award-number":["101136728"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union within the VITAL Horizon Europe project","award":["101136728"],"award-info":[{"award-number":["101136728"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union within the VITAL Horizon Europe project","award":["101136728"],"award-info":[{"award-number":["101136728"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We developed a workflow based on a human-derived dataset, aiming to predict the human heart-to-plasma partition coefficient,\n                    <jats:inline-formula>\n                      <jats:tex-math>$$\\:{K}_{p}$$<\/jats:tex-math>\n                    <\/jats:inline-formula>\n                    . The workflow combines established mechanistic tissue-composition models with an AI\/ML-based selector that supports compound-specific selection among mechanistic heart\n                    <jats:inline-formula>\n                      <jats:tex-math>$$\\:{K}_{p}$$<\/jats:tex-math>\n                    <\/jats:inline-formula>\n                    prediction methods. Three published mechanistic approaches were implemented and parameterized in a harmonized manner consistent with the described methodologies to generate baseline\n                    <jats:inline-formula>\n                      <jats:tex-math>$$\\:{K}_{p}$$<\/jats:tex-math>\n                    <\/jats:inline-formula>\n                    predictions. The ML-based selector was trained using physicochemical, ADME, and pharmacokinetic descriptors to recognize compound-specific differences in model performance. This hybrid strategy preserves mechanistic interpretability while using empirical pattern recognition to formalize a priori model choice across compounds. In internal cross-validation, the selector reduced extreme outliers and provided a reproducible, data-driven rule for compound-specific method selection, although it did not materially outperform the strongest standalone mechanistic baseline in numerical error. Although no individual mechanistic method performed consistently across the full chemical space, the Poulin\u2013Theil approach showed the best overall performance on human whole-heart data. The workflow was also applied prospectively to transthyretin stabilizers, for which reliable heart\n                    <jats:inline-formula>\n                      <jats:tex-math>$$\\:{K}_{p}$$<\/jats:tex-math>\n                    <\/jats:inline-formula>\n                    estimates may support further mechanistic modelling of cardiac drug exposure and downstream pharmacological effects. Together, these findings suggest that combining mechanistic calculators with an AI\/ML-based selector may provide a practical basis for a priori, compound-specific method selection, reducing reliance on subjective choice of a single mechanistic approach.\n                  <\/jats:p>","DOI":"10.1007\/s10928-026-10057-4","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:52:25Z","timestamp":1790340745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Formalizing method choice: a data-driven selection of mechanistic models for predicting human heart drug partitioning"],"prefix":"10.1007","volume":"53","author":[{"given":"Seweryn","family":"Ulaszek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartek","family":"Lisowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Jesionek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wi\u015bniowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"10057_CR1","doi-asserted-by":"publisher","unstructured":"Poulin P, Theil F (Jan. 2000) A Priori Prediction of Tissue:Plasma Partition Coefficients of Drugs to Facilitate the Use of Physiologically-Based Pharmacokinetic Models in Drug Discovery. J Pharm Sci 89(1):16\u201335. https:\/\/doi.org\/10.1002\/(SICI)1520-6017(200001)89:1%3C16::AID-JPS3%3E3.0.CO;2-E","DOI":"10.1002\/(SICI)1520-6017(200001)89:1%3C16::AID-JPS3%3E3.0.CO;2-E"},{"issue":"6","key":"10057_CR2","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jps.20322","volume":"94","author":"T Rodgers","year":"2005","unstructured":"Rodgers T, Leahy D, Rowland M (2005) Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci 94(6):1259\u20131276. https:\/\/doi.org\/10.1002\/jps.20322","journal-title":"J Pharm Sci"},{"issue":"6","key":"10057_CR3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/jps.20502","volume":"95","author":"T Rodgers","year":"2006","unstructured":"Rodgers T, Rowland M (2006) Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci 95(6):1238\u20131257. https:\/\/doi.org\/10.1002\/jps.20502","journal-title":"J Pharm Sci"},{"key":"10057_CR4","doi-asserted-by":"publisher","unstructured":"Schmitt W (Mar. 2008) General approach for the calculation of tissue to plasma partition coefficients. Toxicol Vitro 22(2):457\u2013467. https:\/\/doi.org\/10.1016\/j.tiv.2007.09.010","DOI":"10.1016\/j.tiv.2007.09.010"},{"issue":"3","key":"10057_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11095-016-2086-y","volume":"34","author":"K Korzekwa","year":"2017","unstructured":"Korzekwa K, Nagar S (2017) Drug distribution part 2. Predicting volume of distribution from plasma protein binding and membrane partitioning. Pharm Res 34(3):544\u2013551. https:\/\/doi.org\/10.1007\/s11095-016-2086-y","journal-title":"Pharm Res"},{"issue":"6","key":"10057_CR6","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1002\/jps.21130","volume":"97","author":"R Jansson","year":"2008","unstructured":"Jansson R, Bredberg U, Ashton M (2008) Prediction of drug tissue to plasma concentration ratios using a measured volume of distribution in combination with lipophilicity. J Pharm Sci 97(6):2324\u20132339. https:\/\/doi.org\/10.1002\/jps.21130","journal-title":"J Pharm Sci"},{"key":"10057_CR7","doi-asserted-by":"publisher","unstructured":"Arundel PA (1997) A Multi-Compartmental Model Generally Applicable to Physiologically-Based Pharmacokinetics, IFAC Proc. Vol., vol. 30, no. 2, pp. 129\u2013133, Mar. https:\/\/doi.org\/10.1016\/S1474-6670(17)44557-5","DOI":"10.1016\/S1474-6670(17)44557-5"},{"issue":"10","key":"10057_CR8","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1002\/jps.22553","volume":"100","author":"RD Jones","year":"2011","unstructured":"Jones RD et al (2011) PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution. J Pharm Sci 100(10):4074\u20134089. https:\/\/doi.org\/10.1002\/jps.22553","journal-title":"J Pharm Sci"},{"issue":"1","key":"10057_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10928-013-9342-0","volume":"41","author":"YE Yun","year":"2014","unstructured":"Yun YE, Cotton CA, Edginton AN (2014) Development of a decision tree to classify the most accurate tissue-specific tissue to plasma partition coefficient algorithm for a given compound. J Pharmacokinet Pharmacodyn 41(1):1\u201314. https:\/\/doi.org\/10.1007\/s10928-013-9342-0","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10057_CR10","unstructured":"Green D (2018) Physiologically Based Pharmacokinetic Analyses \u2014 Format and Content Guidance for Industry, Aug. [Online]. Available: https:\/\/www.fda.gov\/files\/drugs\/published\/Physiologically-Based-Pharmacokinetic-Analyses-%E2%80%94-Format-and-Content-Guidance-for-Industry.pdf?utm_source=chatgpt.com"},{"key":"10057_CR11","doi-asserted-by":"publisher","unstructured":"Ulaszek S, Lisowski B, Wi\u015bniowska B, Polak S (2026) Exploring Tafamidis Effects Through PBPK-QSP Modelling, Feb. 09, Medicine and Pharmacology. https:\/\/doi.org\/10.20944\/preprints202602.0585.v1","DOI":"10.20944\/preprints202602.0585.v1"},{"issue":"6","key":"10057_CR12","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/jps.20073","volume":"93","author":"LM Berezhkovskiy","year":"2004","unstructured":"Berezhkovskiy LM (2004) Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination. J Pharm Sci 93(6):1628\u20131640. https:\/\/doi.org\/10.1002\/jps.20073","journal-title":"J Pharm Sci"},{"issue":"5","key":"10057_CR13","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/jps.10128","volume":"91","author":"P Poulin","year":"2002","unstructured":"Poulin P, Theil FP (2002) Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. J Pharm Sci 91(5):1358\u20131370. https:\/\/doi.org\/10.1002\/jps.10128","journal-title":"J Pharm Sci"},{"issue":"6","key":"10057_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/bdd.1944","volume":"36","author":"Z Tylutki","year":"2015","unstructured":"Tylutki Z, Polak S (2015) Plasma vs heart tissue concentration in humans \u2013 literature data analysis of drugs distribution. Biopharm Drug Dispos 36(6):337\u2013351. https:\/\/doi.org\/10.1002\/bdd.1944","journal-title":"Biopharm Drug Dispos"},{"issue":"W1","key":"10057_CR15","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L et al (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52(W1):W422\u2013W431. https:\/\/doi.org\/10.1093\/nar\/gkae236","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10057_CR16","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G et al (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49(W1):W5\u2013W14. https:\/\/doi.org\/10.1093\/nar\/gkab255","journal-title":"Nucleic Acids Res"},{"key":"10057_CR17","unstructured":"PubChem Identifier Exchange Service. Accessed: Sep. 08, 2025. [Online]. Available: https:\/\/pubchem.ncbi.nlm.nih.gov\/idexchange\/idexchange.cgi"},{"issue":"2","key":"10057_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/1573406411309020002","volume":"9","author":"KM Honorio","year":"2013","unstructured":"Honorio KM, Moda TL, Andricopulo AD (2013) Pharmacokinetic properties and in silico ADME modeling in drug discovery. Med Chem 9(2):163\u2013176. https:\/\/doi.org\/10.2174\/1573406411309020002","journal-title":"Med Chem"},{"key":"10057_CR19","doi-asserted-by":"publisher","DOI":"10.1039\/9781782622376-00001","author":"M Karlgren","year":"2015","unstructured":"Karlgren M, Bergstr\u00f6m CAS (2015) How Physicochemical Properties of Drugs Affect Their Metabolism and Clearance. Nov. https:\/\/doi.org\/10.1039\/9781782622376-00001","journal-title":"Nov"},{"issue":"7","key":"10057_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/psp4.12791","volume":"11","author":"U Ezuruike","year":"2022","unstructured":"Ezuruike U et al (2022) Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator. CPT Pharmacomet Syst Pharmacol 11(7):805\u2013821. https:\/\/doi.org\/10.1002\/psp4.12791","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"1","key":"10057_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L (2001) Random forests. Mach Learn 45(1):5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324","journal-title":"Mach Learn"},{"key":"10057_CR22","doi-asserted-by":"publisher","unstructured":"Chen T, Guestrin C (2016) XGBoost: A Scalable Tree Boosting System, in Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, in KDD \u201916. New York, NY, USA: Association for Computing Machinery, Aug. pp. 785\u2013794. https:\/\/doi.org\/10.1145\/2939672.2939785","DOI":"10.1145\/2939672.2939785"},{"key":"10057_CR23","doi-asserted-by":"publisher","unstructured":"Hoerl AE, Kennard RW (1970) Ridge Regression: Biased Estimation for Nonorthogonal Problems, Technometrics, 12(1):55\u201367. https:\/\/doi.org\/10.1080\/00401706.1970.10488634","DOI":"10.1080\/00401706.1970.10488634"},{"key":"10057_CR24","doi-asserted-by":"publisher","unstructured":"Knightes CD, Cyterski M (2005) Evaluating predictive errors of a complex environmental model using a general linear model and least square means. Ecol Model 186(3):366\u2013374. https:\/\/doi.org\/10.1016\/j.ecolmodel.2005.01.034","DOI":"10.1016\/j.ecolmodel.2005.01.034"},{"key":"10057_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics18030367","author":"S Ulaszek","year":"2026","unstructured":"Ulaszek S, Lisowski B, Wi\u015bniowska B, Polak S (2026) Exploring tafamidis effects through PBPK\u2013QSP modelling. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics18030367","journal-title":"Pharmaceutics"},{"key":"10057_CR26","volume-title":"Pattern recognition and machine learning. in Information science and statistics","author":"CM Bishop","year":"2006","unstructured":"Bishop CM (2006) Pattern recognition and machine learning. in Information science and statistics. Springer, New York"},{"issue":"1","key":"10057_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J (1960) A Coefficient of Agreement for Nominal Scales. Educ Psychol Meas 20(1):37\u201346. https:\/\/doi.org\/10.1177\/001316446002000104","journal-title":"Educ Psychol Meas"},{"key":"10057_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The Elements of Statistical Learning. in Springer Series in Statistics","author":"T Hastie","year":"2009","unstructured":"Hastie T, Tibshirani R, Friedman J (2009) The Elements of Statistical Learning. in Springer Series in Statistics. Springer, New York, NY. https:\/\/doi.org\/10.1007\/978-0-387-84858-7"},{"key":"10057_CR29","doi-asserted-by":"publisher","unstructured":"Team RC (2024) A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Oct 31. https:\/\/doi.org\/10.32614\/R.manuals","DOI":"10.32614\/R.manuals"},{"issue":"3","key":"10057_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/psp4.12915","volume":"12","author":"E Yau","year":"2023","unstructured":"Yau E, Gertz M, Ogungbenro K, Aarons L, Olivares-Morales A (2023) A \u2018middle-out approach\u2019 for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models. CPT Pharmacomet Syst Pharmacol 12(3):346\u2013359. https:\/\/doi.org\/10.1002\/psp4.12915","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"2","key":"10057_CR31","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.xphs.2024.12.018","volume":"114","author":"M Ning","year":"2025","unstructured":"Ning M et al (Feb.2025) A cross-species assessment of in silico prediction methods of steady-state volume of distribution using Simcyp simulators. J Pharm Sci 114(2):1410\u20131422. https:\/\/doi.org\/10.1016\/j.xphs.2024.12.018","journal-title":"J Pharm Sci"},{"issue":"7","key":"10057_CR32","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.xphs.2020.04.002","volume":"109","author":"K Mayumi","year":"2020","unstructured":"Mayumi K, Tachibana M, Yoshida M, Ohnishi S, Kanazu T, Hasegawa H (2020) The novel in vitro method to calculate tissue-to-plasma partition coefficient in humans for predicting pharmacokinetic profiles by physiologically-based pharmacokinetic model with high predictability. J Pharm Sci 109(7):2345\u20132355. https:\/\/doi.org\/10.1016\/j.xphs.2020.04.002","journal-title":"J Pharm Sci"},{"issue":"9","key":"10057_CR33","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1021\/acs.jcim.4c00046","volume":"64","author":"K Handa","year":"2024","unstructured":"Handa K, Yoshimura S, Kageyama M, Iijima T (2024) Development of novel methods for QSAR modeling by machine learning repeatedly: a case study on drug distribution to each tissue. J Chem Inf Model 64(9):3662\u20133669. https:\/\/doi.org\/10.1021\/acs.jcim.4c00046","journal-title":"J Chem Inf Model"},{"issue":"11","key":"10057_CR34","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/acs.jcim.6b00229","volume":"56","author":"E Dolgikh","year":"2016","unstructured":"Dolgikh E et al (Nov.2016) QSAR Model of Unbound Brain-to-Plasma Partition Coefficient,\u00a0Kp, uu, brain: Incorporating P-glycoprotein Efflux as a Variable. J Chem Inf Model 56(11):2225\u20132233. https:\/\/doi.org\/10.1021\/acs.jcim.6b00229","journal-title":"J Chem Inf Model"},{"issue":"10","key":"10057_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1124\/dmd.120.090498","volume":"48","author":"K Utsey","year":"2020","unstructured":"Utsey K, Gastonguay MS, Russell S, Freling R, Riggs MM, Elmokadem A (2020) Quantification of the impact of partition coefficient prediction methods on physiologically based pharmacokinetic model output using a standardized tissue composition. Drug Metab Dispos 48(10):903\u2013916. https:\/\/doi.org\/10.1124\/dmd.120.090498","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10057-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-026-10057-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10057-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:03:35Z","timestamp":1790384615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-026-10057-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10057"],"URL":"https:\/\/doi.org\/10.1007\/s10928-026-10057-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9969413\/v1","asserted-by":"object"}]},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"56"}}